ABSTRACT Bacillus velezensis CE2 produces potent antimicrobial compound(s). The draft genome sequence of the strain reported here is 4.1 Mb with a GϩC content of 46.1%. Whole-genome sequencing revealed that the strain genetically encodes a novel multicomponent lantibiotic, velezensicidin.
in the genome. To the best of our knowledge, the amino acid sequences encoded by the structural genes for the two-component lantibiotic were not reported elsewhere in published literature. The production of potent antimicrobial activity and presence of a novel lantibiotic structural gene indicate the potential usefulness of B. velezensis CE2 in food or agriculture.
Data availability. Assembled and raw reads can be found at the 100K Project BioProject (accession number PRJNA203445) in the Sequence Read Archive (https:// www.ncbi.nlm.nih.gov/sra). The accession number for the DDBJ/ENA/GenBank assembly is RBZX00000000 and reads are in the SRA under the accession number SRR7965938. The sample information can be found under BioSample accession number SAMN10178429. The assembly version described here is version RBZX01000000.
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